Ads
related to: fda cancer
Search results
FDA approves bladder cancer treatment by Culver City company
LA Times via Yahoo News· 3 days agoFDA action and called Anktiva "a next-generation immunotherapy." The drug itself is designed to...
Is the FDA Pausing More Cancer Trials? It's Hard to Tell
Medscape· 2 days agoIs the FDA Pressing Pause on More Cancer Trials? In October, the US Food and Drug Administration (...
Compass gains FDA Fast Track status for biliary tract cancer candidate
Seeking Alpha· 16 hours agoCompass Therapeutics receives FDA Fast Track designation for CTX-009 in combination with paclitaxel...
FDA Approves New Bladder Cancer Drug
Medscape· 3 days agoThe first-in-class agent is approved alongside bacillus Calmette-Guérin to treat certain non–muscle-invasive bladder cancers that do not respond to...
FDA Approves ImmunityBio's Bladder Cancer Drug, Stock Rallies
Benzinga via Yahoo Finance· 3 days ago(N-803, or nogapendekin alfa inbakicept-pmln) plus Bacillus Calmette-Guérin (BCG) for...
...PROFIT TO FURTHER ADVANCEMENTS IN PEDIATRIC BRAIN CANCER, ANNOUNCES FDA APPROVAL OF TOVORAFENIB...
ThePress.net· 2 days agoThe Pediatric Neuro-Oncology Consortium Foundation (PNOC Foundation), a platinum rated non-profit dedicated to supporting advancements in childhood brain cancer research and ...
FDA Mandates "Boxed Warning" For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therapies...
Benzinga· 7 days agoFollowing an investigation announced in November last year, the FDA said on Thursday that it would...
FDA grants Medivir´s MIV-711 Rare Pediatric Disease Designation and Orphan Drug Designation for the...
FOX 59 Indianapolis· 1 day ago(NASDAQ: MVIR) (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for...
ImmunityBio stock jumps as FDA clears bladder cancer therapy (NASDAQ:IBRX)
Seeking Alpha· 3 days agoShares of ImmunityBio (IBRX) surged 33% premarket after FDA clearance of its combination therapy for...
HOOKIPA advances HPV cancer trial with FDA nod By Investing.com
Investing.com· 13 hours agoThe trial design, which aligns with U.S. Food and Drug Administration (FDA) feedback, is set to...
